©PDC*line
Novadip’s NVDX3 reaches key milestones leading to IND approval from FDA to start phase 2b/3 study in cervical spine fusion
© Novadip
Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a stem-cell derived bone graft alternative
©No copyright
Ciliatech presents 36-month follow-up data on novel CID implant, Intercil® Uveal Spacer, for treating glaucoma
©Westend61 – Alamy
QuantaMatrix unveils world’s fastest antimicrobial testing technology backed by research paper in Nature
(C) Shutterstock
Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate combined with immune checkpoint inhibitors
© Pamela Chemla
AACR 2024: PDC*line Pharma presents interim clinical results from last cohort of patients in phase I/II trial with PDC*lung01 cancer vaccine
© PDC*Line
Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure
© iStock
Carthera: positive results from phase I/II clinical trial of SonoCloud-9 in treatment of glioblastoma published in Nature Communications
© Shuttershock / Jaray Shanshed
Carthera enrolls first patient in pivotal trial of SonoCloud-9® device for treatment of recurrent glioblastoma
©Carthera